Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|April 1, 2015
Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activationEleonora Patsenker, Philip Sachse, Andrea Chicca, et al.Organic & Biomolecular Chemistry|July 18, 2015
Reactions of CF3-enones with arenes under superelectrophilic activation: a pathway to trans-1,3-diaryl-1-CF3-indanes, new cannabinoid receptor ligandsRoman O Iakovenko, Anna N Kazakova, Vasiliy M Muzalevskiy, et al.European Journal of Medicinal Chemistry|October 12, 2020
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsCarlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.Journal of Medicinal Chemistry|May 6, 2022
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine DerivativesGiulia Bononi, Miriana Di Stefano, Giulio Poli, et al.European Journal of Medicinal Chemistry|August 26, 2018
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitorsGiulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.Journal of Medicinal Chemistry|January 9, 2018
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) InhibitorsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptakeAndrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.Molecular Psychiatry|August 22, 2018
Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairmentsFrancesco Petrelli, Glenn Dallérac, Luca Pucci, et al.European Journal of Medicinal Chemistry|November 17, 2023
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitorsMiriana Di Stefano, Samuele Masoni, Giulia Bononi, et al.European Journal of Medicinal Chemistry|October 1, 2020
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosisChiara Arena, Francesca Gado, Lorenzo Di Cesare Mannelli, et al.Pageof 6